Glucose-Dependent Insulinotropic Polypeptide Receptors in Most Gastroenteropancreatic and Bronchial Neuroendocrine Tumors | Zendy

Beatrice Waser | Zendy; Ruth Rehmann | Zendy; Claire Sanchez | Zendy; Daniel Fourmy | Zendy; Jean Claude Reubi | Zendy

Open Access

Glucose-Dependent Insulinotropic Polypeptide Receptors in Most Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Author(s) -

Beatrice Waser,

Ruth Rehmann,

Claire Sanchez,

Daniel Fourmy,

Jean Claude Reubi

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2454

Subject(s) - somatostatin receptor , receptor , medicine , endocrinology , somatostatin , somatostatin receptor 2 , gastric inhibitory polypeptide , receptor expression , biology , neuroendocrine tumors , cancer research , glucagon , hormone

Gastrointestinal peptide hormone receptors overexpressed in neuroendocrine tumors (NET), such as somatostatin or glucagon-like peptide-1 (GLP-1) receptors, are used for in vivo tumor targeting. Unfortunately, not all NET express these receptors sufficiently.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research